-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...

-The Times of India The Supreme Court on Thursday lifted the omnibus ban on iron ore mines in Bellary, Chitradurga and Tumkur districts of Karnataka and permitted 81 lease owners, who had committed minor violations, to resume mining after compliance of stringent conditions laid down by the courts. Moving forward from its reference to illegal mining activity for decades under active political patronage as "a shocking state of depredation of nature's bounty...

-The Telegraph JALNA AND AHMEDNAGAR: Sakharam Misal is frank. Water, he says, is big business. In Jalna district, which has run out of water, the man in his late 50s is among the most sought after. He runs a water tanker business and sells water to the thirsty millions. Misal's cellphone keeps ringing with desperate calls for water. His tankers are booked in advance and the waiting list stretches over a week. Drought,...

-The Telegraph Dairy farmer Nivrutti Bhagwan Gaikwad, 42, wanted to take no chances with nature. A hardworking and enterprising man, he built his cattle shed scientifically in consultation with livestock experts, installing air coolers and filtered-water pipelines for his cattle, building separate compartments for the cows and the buffaloes, and erecting a fodder godown. He used high-quality cans to collect and transport the 180 litres of milk his 50 cows and buffaloes produced...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...